Brandinium

Trademark search for:

DYPROTEX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 1988-02-18 — Application filed
  • 1988-04-18 — Assigned to examiner
  • 1988-05-23 — Approved for pub - principal register
  • 1988-06-24 — Notice of publication
  • 1988-07-26 — Published for opposition
  • 1988-10-18 — Registered-principal register
  • 1993-11-03 — Registered - sec. 8 (6-yr) & sec. 15 filed
  • 1994-03-16 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2002-06-17 — Teas change of correspondence received
  • 2003-09-30 — Teas change of correspondence received
  • 2006-04-12 — Teas change of correspondence received
  • 2008-01-02 — Automatic update of assignment of ownership
  • 2008-07-09 — Case file in ticrs
  • 2008-10-20 — Teas section 8 & 9 received
  • 2008-10-24 — Assigned to paralegal
  • 2008-10-30 — Registered and renewed (first renewal - 10 yrs)
  • 2008-10-30 — Registered - sec. 8 (10-yr) accepted/sec. 9 granted
  • 2013-11-27 — Teas change of correspondence received
  • 2017-10-18 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2021-10-15 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2021-10-15 — Final status recorded

Owner Information

MEDIBRANDS LTD.
YOKNEAM ELIT IL
BLISTEX INC.
OAK BROOK , IL
BLISTEX INC.
OAK BROOK , IL
BLISTEX INC.
OAK BROOK , IL

Correspondent

Joseph T. Kucala, Jr. Norvell IP llc
PO Box 2461
CHICAGO, IL 60690
UNITED STATES

Filing Details

Filing Date:
1988-02-18
Status Date:
2021-10-15
Category:
Pharmaceuticals
Filing Year:
1988

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.